Mesoblast Ltd banner

Mesoblast Ltd
NASDAQ:MESO

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
NASDAQ:MESO
Watchlist
Price: 16.67 USD -1.3% Market Closed
Market Cap: $1.9B

Wall Street
Price Targets

MESO Price Targets Summary
Mesoblast Ltd

Wall Street analysts forecast MESO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MESO is 18.46 USD with a low forecast of 17.96 USD and a high forecast of 19.51 USD.

Lowest
Price Target
17.96 USD
8% Upside
Average
Price Target
18.46 USD
11% Upside
Highest
Price Target
19.51 USD
17% Upside
Mesoblast Ltd Competitors:
Price Targets
PWP
Perella Weinberg Partners
13% Upside
CIGI
Colliers International Group Inc
17% Upside
SUPN
Supernus Pharmaceuticals Inc
23% Upside
OFIX
Orthofix Medical Inc
55% Upside
QLYS
Qualys Inc
39% Upside
CYBR
Cyberark Software Ltd
21% Upside
WLFC
Willis Lease Finance Corp
-17% Downside

Revenue
Forecast

-1% / Year
Past Growth
177% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
-1% / Year
Past Growth
177% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

For the last 14 years the compound annual growth rate for Mesoblast Ltd's revenue is -1%. The projected CAGR for the next 3 years is 177%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MESO's stock price target?
Price Target
18.46 USD

According to Wall Street analysts, the average 1-year price target for MESO is 18.46 USD with a low forecast of 17.96 USD and a high forecast of 19.51 USD.

What is Mesoblast Ltd's Revenue forecast?
Projected CAGR
177%

For the last 14 years the compound annual growth rate for Mesoblast Ltd's revenue is -1%. The projected CAGR for the next 3 years is 177%.

Back to Top